Filter Results:
(7,886)
Show Results For
- All HBS Web
(7,886)
- People (21)
- News (2,644)
- Research (4,134)
- Events (21)
- Multimedia (297)
- Faculty Publications (3,373)
Show Results For
- All HBS Web
(7,886)
- People (21)
- News (2,644)
- Research (4,134)
- Events (21)
- Multimedia (297)
- Faculty Publications (3,373)
- Video
Said Darwazah
Said Darwazah, Executive Chairman and CEO of Hikma Pharmaceuticals PLC, speaks about the importance of hiring local employees to help lead the company’s expansions into new markets, particularly in the context of political crises such as the Arab Spring or health... View Details
- Web
Employment Data
3% Entertainment / Media 3% Health Care 6% Investment Banking 5% Investment Management / Hedge Fund 6% Manufacturing 5% Nonprofit / Government 5% Other Financial Services 4% Private Equity 19% Retail 2% Services 3% Technology 16% Venture... View Details
- 10 Feb 2016
- News
Can OSHA Inspections Be Made More Effective?
- 11 Jun 2015
- Video
HBS Leadership Fellows: Making an Impact
- 04 Oct 2013
- News
Medical Device Tax Might Be Way To Get A Budget Passed
- September 2013 (Revised January 2016)
- Case
The Abraaj Group and the Acibadem Healthcare Investment (A)
By: Paul A. Gompers, Bora Uluduz and Firdevs Abacioglu
This case concerns the proposed buyout of Acibadem, a leading hospital chain in Turkey. Abraaj, a MENA region private equity firm, proposes to make its first investment in Turkey. The case highlights the role of Turkish health care reform in driving the value. The... View Details
Gompers, Paul A., Bora Uluduz, and Firdevs Abacioglu. "The Abraaj Group and the Acibadem Healthcare Investment (A)." Harvard Business School Case 214-021, September 2013. (Revised January 2016.)
- Program
Leading in the Digital Era
and in the larger classroom, driven by the renowned HBS case method. Review Our Campus Health & Safety Protocols Admissions Criteria and Process We admit candidates to specific sessions on a rolling, space-available basis, and encourage... View Details
- 12 Nov 2021
- HBS Seminar
Prof. Rosabeth Moss Kanter, HBS
- 2008
- Simulation
Everest Leadership and Team Simulation
By: Michael A. Roberto and Amy C. Edmondson
This item is currently not available for purchase on this site. To order, please contact Customer Service - (800) 545-7685 or (617) 783-7600. **REVISED AUGUST 2009!** This web-based simulation uses the dramatic context of a Mount Everest expedition to reinforce student... View Details
- 2018
- Article
Knowledge about Tuberculosis and Infection Prevention Behavior: A Nine City Longitudinal Study from India
By: Sophie Huddart, Thomas Bossuroy, Vincent Pons, Siddhartha Baral, Madhukar Pai and Clara Delavallade
Background
Improving patients’ tuberculosis (TB) knowledge is a salient component of TB control strategies. Patient knowledge of TB may encourage infection prevention behaviors and improve treatment adherence. The purpose of this study is to examine how... View Details
Improving patients’ tuberculosis (TB) knowledge is a salient component of TB control strategies. Patient knowledge of TB may encourage infection prevention behaviors and improve treatment adherence. The purpose of this study is to examine how... View Details
Huddart, Sophie, Thomas Bossuroy, Vincent Pons, Siddhartha Baral, Madhukar Pai, and Clara Delavallade. "Knowledge about Tuberculosis and Infection Prevention Behavior: A Nine City Longitudinal Study from India." PLoS ONE 13, no. 10 (2018).
- October 2011 (Revised December 2012)
- Case
eHealthpoint: Healthcare for Rural India
By: Richard G. Hamermesh, Mona Sinha and Elizabeth Vrolyk
Healthpoint Services sought to address rural India's shortage of quality and affordable healthcare with a multi-service platform that comprised telemedical health clinics called eHealthpoints, clean drinking water, a diagnostic lab, and a pharmacy. Could they convince... View Details
Hamermesh, Richard G., Mona Sinha, and Elizabeth Vrolyk. "eHealthpoint: Healthcare for Rural India." Harvard Business School Case 812-020, October 2011. (Revised December 2012.)
Managing in a Complex Environment
For the first time in anybody's memory we're starting to see the biopharmaceutical industry and the medical industry at large affected by a recession. I think there are a couple of reasons. One is very high unemployment, and every time the unemployment rate goes up,... View Details
- Web
Faculty & Advisors | MBA
Faculty & Advisors MS/MBA Biotechnology: Life Sciences Faculty Amitabh Chandra, Ph.D. Henry and Allison McCance Professor of Business Administration at HBS, Ethel Zimmerman Winer Professor of Public Policy and Director of Health Policy... View Details
- Program
Senior Executive Leadership Program—India
carefully designed to facilitate your growth. Your learning will take place on your own, in your small learning group, and in the larger classroom, driven by the renowned HBS case method. Review Our Campus Health & Safety Protocols Read... View Details
- 14 Sep 2017
- News
Study: US Government Its Own Worst Enemy
- 2024
- Working Paper
Health, Human Capital Development and the Longevity of Japanese Elites Since 710
By: Tom Nicholas and Hiroshi Shimizu
We examine the lifespan of over 40,000 elites in Japan born between 710 and 1912, including samurai warriors, feudal lords, business, political, cultural, and religious leaders at the apex of the social hierarchy. Japanese elites experienced increases in lifespan about... View Details
Nicholas, Tom, and Hiroshi Shimizu. "Health, Human Capital Development and the Longevity of Japanese Elites Since 710." Working Paper, June 2024.
- 31 Oct 2017
- News
Giving Doctors What They Need to Avoid Burnout
- 02 Mar 2023
- Blog Post
Women, Work, and the "M" Word
I’m the eldest of three daughters in a medical family. With a urogynecologist and primary care doctor as parents, I grew up thinking it was normal to talk about all topics of women’s health around the dinner table, from menstruation to... View Details
- March 2014 (Revised November 2020)
- Case
The Novartis Malaria Initiative
By: Michael Chu, Vincent Marie Dessain and Emilie Billaud
The Novartis Malaria Initiative was designed, as a result of a precedent–setting agreement with the World Health Organization in 2001, to provide a breakthrough treatment for malaria—"at no profit"—for public health systems. What had begun as an exemplary act of... View Details
Keywords: Health Care and Treatment; Product Marketing; Corporate Social Responsibility and Impact; Social Enterprise; Pharmaceutical Industry; Switzerland; Africa; Nigeria
Chu, Michael, Vincent Marie Dessain, and Emilie Billaud. "The Novartis Malaria Initiative." Harvard Business School Case 314-103, March 2014. (Revised November 2020.)